A new field of science claims to be able to predict aesthetic traits, intelligence, and even moral character in embryos. Is this the next step in human evolution or something more dangerous? Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of a grain of sand pulled from a powdery white Caribbean beach, contains the coiled potential of a future life: 46 chromosomes, thousands of genes, and roughly six billion base pairs of DNA--an instruction manual to assemble a one-of-a-kind human. Now imagine a laser pulse snipping a hole in the blastocyst's outermost shell so a handful of cells can be suctioned up by a microscopic pipette. This is the moment, thanks to advances in genetic sequencing technology, when it becomes possible to read virtually that entire instruction manual. An emerging field of science seeks to use the analysis pulled from that procedure to predict what kind of a person that embryo might become. Some parents turn to these tests to avoid passing on devastating genetic disorders that run in their families. A much smaller group, driven by dreams of Ivy League diplomas or attractive, well-behaved offspring, are willing to pay tens of thousands of dollars to optimize for intelligence, appearance, and personality. Some of the most eager early boosters of this technology are members of the Silicon Valley elite, including tech billionaires like Elon Musk, Peter Thiel, and Coinbase CEO Brian Armstrong. Embryo selection is less like a build-a-baby workshop and more akin to a store where parents can shop for their future children from several available models--complete with stat cards. But customers of the companies emerging to provide it to the public may not be getting what they're paying for. Genetics experts have been highlighting the potential deficiencies of this testing for years.

A Stanford University-led team of scientists has developed a machine learning tool that can analyse electronic healthcare records (EHR) to identify individuals who are likely to have familial hypercholesterolemia (FH), an underdiagnosed genetic cause of elevated low-density lipoprotein (LDL) cholesterol, which puts patients at a 20-fold increased risk of coronary artery disease. In separate test runs the classifier, described today in npj Digital Medicine, correctly identified more than 80% of cases--its positive predictive value (PPV)--and demonstrated 99% specificity. The team says the classifier could help to flag up patients who are most likely to have FH, so that they and their families can undergo further genetic testing. "Theoretically, when someone comes into the clinic with high cholesterol or heart disease, we would run this algorithm," said Nigam Shah, MBBS, PhD, Stanford University associate professor of medicine and biomedical data science. "If they're flagged, it means there's an 80% chance that they have FH. Those few individuals could then get sequenced to confirm the diagnosis and could start an LDL-lowering treatment right away."

The use of artificial intelligence in medicine is generating great excitement and hope for treatment advances. AI generally refers to computers' ability to mimic human intelligence and to learn. For example, by using machine learning, scientists are working to develop algorithms that will help them make decisions about cancer treatment. They hope that computers will be able to analyze radiological images and discern which cancerous tumors will respond well to chemotherapy and which will not. But AI in medicine also raises significant legal and ethical challenges.

The use of artificial intelligence in medicine is generating great excitement and hope for treatment advances. AI generally refers to computers' ability to mimic human intelligence and to learn. For example, by using machine learning, scientists are working to develop algorithms that will help them make decisions about cancer treatment. They hope that computers will be able to analyze radiological images and discern which cancerous tumors will respond well to chemotherapy and which will not. But AI in medicine also raises significant legal and ethical challenges.

The use of artificial intelligence in medicine is generating great excitement and hope for treatment advances. AI generally refers to computers' ability to mimic human intelligence and to learn. For example, by using machine learning, scientists are working to develop algorithms that will help them make decisions about cancer treatment. They hope that computers will be able to analyze radiological images and discern which cancerous tumors will respond well to chemotherapy and which will not. But AI in medicine also raises significant legal and ethical challenges.

The use of artificial intelligence in medicine is generating great excitement and hope for treatment advances. AI generally refers to computers' ability to mimic human intelligence and to learn. For example, by using machine learning, scientists are working to develop algorithms that will help them make decisions about cancer treatment. They hope that computers will be able to analyze radiological images and discern which cancerous tumors will respond well to chemotherapy and which will not. But AI in medicine also raises significant legal and ethical challenges.

The use of artificial intelligence in medicine is generating great excitement and hope for treatment advances. AI generally refers to computers' ability to mimic human intelligence and to learn. For example, by using machine learning, scientists are working to develop algorithms that will help them make decisions about cancer treatment. They hope that computers will be able to analyze radiological images and discern which cancerous tumors will respond well to chemotherapy and which will not. But AI in medicine also raises significant legal and ethical challenges.

The use of artificial intelligence in medicine is generating great excitement and hope for treatment advances. AI generally refers to computers' ability to mimic human intelligence and to learn. For example, by using machine learning, scientists are working to develop algorithms that will help them make decisions about cancer treatment. They hope that computers will be able to analyze radiological images and discern which cancerous tumors will respond well to chemotherapy and which will not. But AI in medicine also raises significant legal and ethical challenges.

In Shenzhen, even kindergartners have homework. You can see it in the workbook-laden backpacks weighing them down as they waddle through the school gates at 8 a.m. and back out again at 5 p.m. Many are not headed home yet. There are dance classes, piano lessons, English tutors, kung-fu sessions to get to. After classes, after dinner, it is time to tackle that homework.

NEW YORK (CBSNewYork) – Could artificial intelligence help doctors diagnose diseases just by looking at faces? When you hear facial recognition you probably think about crime fighting or Homeland Security screening for terrorists. It turns out a person's face can tell a lot about their genetic makeup and the medical conditions it may cause, and a computer can learn to read those differences, CBS2's Dr. Max Gomez reported. "We've learned, surprisingly, that many thousands of genetic rare diseases have a unique facial appearances," Dekel Gelbman told Gomez. Gelbman is the CEO of artificial intelligence company FDNA.